{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:48:27Z","timestamp":1788961707998,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Deep vein thrombosis of the upper limb is a rare but clinically significant condition, as it may represent the first manifestation of an underlying malignancy and often poses diagnostic and therapeutic challenges. We present the case of a 66-year-old woman with no significant medical history, admitted for extensive deep vein thrombosis of the left upper limb that developed shortly after surgical decompression of the carpal tunnel. Postoperatively, she presented with marked swelling of the left arm, and Doppler ultrasonography confirmed thrombosis of the deep venous system. Thoracic computed tomography illustrated tumoral infiltration of the left subclavian vein and artery, causing segmental venous thrombosis and severe arterial stenosis. Despite elevated serum levels of the tumor marker Cancer Antigen 15-3, both mammography and breast ultrasonography were negative. A thoracic computed tomography\u2013guided biopsy established the diagnosis of invasive lobular breast carcinoma, Nottingham grade 1, estrogen receptor\u2013positive, with Ki-67\u2009&amp;lt;\u20095%. Staging procedures included positron emission tomography combined with computed tomography, magnetic resonance imaging of the breast, and confirmatory breast biopsy. The particularity of this case lies in its atypical onset, initially mimicking carpal tunnel syndrome, combined with upper limb venous thrombosis caused by an occult breast tumor undetectable by conventional imaging but infiltrating the axillary vascular bundle. Therapeutic decisions followed international guidelines for cancer-associated thrombosis, with anticoagulation tailored to bleeding risk and oncologic therapy individualized according to the tumor's immunologic profile.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Upper extremity deep vein thrombosis is frequently associated with malignancy and may represent its first clinical manifestation, as in our patient, whose axillary breast carcinoma invaded the arteriovenous structures without detectable breast lesions. Early recognition of this condition is essential for timely diagnosis and improved prognosis. Direct oral anticoagulants represent a valuable therapeutic option with multiple advantages. Their potential antineoplastic effects\u2014particularly those of factor XI inhibitors currently under investigation\u2014may provide additional benefits in cancer-associated thrombosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1742549","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:10:11Z","timestamp":1770138611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Upper extremity deep vein thrombosis revealing an occult invasive ductal breast carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Stefan","family":"Chiorescu","sequence":"first","affiliation":[{"name":"Department of Surgery, Iuliu Ha\u021bieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]},{"name":"Department of Surgery, Emergency Clinical County Hospital","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Oiegar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Department of Cardiology Rehabilitation, Iuliu Ha\u021bieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]},{"name":"Doctoral School, Iuliu Ha\u021bieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Mocan","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Iuliu Hatieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]},{"name":"Department of Internal Medicine, Emergency Clinical County Hospital","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Trif","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Emergency Clinical County Hospital","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan Alexandru","family":"Ciocan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emergency Clinical County Hospital","place":["Cluj-Napoca, Romania"]},{"name":"Department of Surgery \u2014 Practical Abilities, Iuliu Hatieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana Mihaela","family":"Chiorescu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Iuliu Hatieganu University of Medicine and Pharmacy","place":["Cluj-Napoca, Romania"]},{"name":"Department of Internal Medicine, Emergency Clinical County Hospital","place":["Cluj-Napoca, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.thromres.2023.11.026","article-title":"Upper extremity venous thrombosis in hospitalized patients: a prospective epidemiological study","volume":"233","author":"Espitia","year":"2024","journal-title":"Thromb Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.14423\/SMJ.0000000000001728","article-title":"Upper extremity deep vein thrombosis: incidence, risk factors, and effectiveness of chemoprophylaxis","volume":"117","author":"Olt","year":"2024","journal-title":"South Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10760296251365626","DOI":"10.1177\/10760296251365626","article-title":"An analysis of incidence, related factors and prophylactic treatments of hospital-acquired upper extremity deep vein thrombosis: a single-center 13-year retrospective study","volume":"31","author":"Wang","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11845-021-02775-0","article-title":"Upper extremity deep venous thrombosis prevalence in the NHS Grampian medical ambulatory clinic: diagnostic, therapeutic, and prognostic considerations in oncology patients","volume":"191","author":"Kastora","year":"2022","journal-title":"Ir J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.32596\/ejcm.galenos.2021-06-039","article-title":"Upper-extremity deep venous thrombosis: analysis of 348 cases","volume":"9","author":"Erdinc","year":"2021","journal-title":"e-J Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e26732","DOI":"10.1097\/MD.0000000000026732","article-title":"A retrospective cohort study of disease-related risk factors for central venous catheter-related symptomatic thrombosis in intensive care unit inpatients","volume":"100","author":"Kuang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e045895","DOI":"10.1136\/bmjopen-2020-045895","article-title":"Catheter-to-vein ratio and risk of peripherally inserted central catheter-associated thrombosis according to diagnostic group: a retrospective cohort study","volume":"11","author":"Sharp","year":"2021","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/pathogens14080816","article-title":"Risk of venous thromboembolism in infectious diseases: a literature review","volume":"14","author":"Pati","year":"2025","journal-title":"Pathogens"},{"key":"B9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-0036-1597764","article-title":"Interventional therapy for upper extremity deep vein thrombosis","volume":"34","author":"Carlon","year":"2017","journal-title":"Semin Intervent Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22551\/2025.48.1203.10324","article-title":"Spontaneous upper extremity deep vein thrombosis as initial manifestation of a malignant mediastinal teratoma","volume":"12","author":"Sucker","year":"2025","journal-title":"Arch Clin Cases"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e33513","DOI":"10.7759\/cureus.33513","article-title":"Upper extremity deep vein thrombosis as the tip of the iceberg: case report and review of literature","volume":"15","author":"Fontes","year":"2023","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.3390\/curroncol28060453","article-title":"Treatment algorithm in cancer-associated thrombosis: updated Canadian expert consensus","volume":"28","author":"Carrier","year":"2021","journal-title":"Curr Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/jcm8101747","article-title":"Oral anticoagulant therapy\u2014when art meets science","volume":"8","author":"Cimpan","year":"2019","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/healthcare9101287","article-title":"Arguments for using direct oral anticoagulants in cancer-related venous thromboembolism","volume":"9","author":"Chiorescu","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/rth2.12359","article-title":"Direct oral anticoagulants compared with low-molecular-weight heparin for the treatment of cancer-associated thrombosis: updated systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Moik","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low-molecular-weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH","volume":"17","author":"Wang","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: aSCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","article-title":"Cancer-associated venous thromboembolic disease, version 2.2024","volume":"22","author":"Streiff","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.critrevonc.2018.06.015","article-title":"Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: clinical consequences","volume":"129","author":"Bellesoeur","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12051144","article-title":"Direct oral anticoagulants in cancer patients: time for a change in paradigm","volume":"12","author":"Wojtukiewicz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jacc.2021.06.010","article-title":"Factor XI inhibition to uncouple thrombosis from hemostasis","volume":"78","author":"Hsu","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood.2023022257","article-title":"Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo","volume":"144","author":"Puy","year":"2024","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/Life13091888","article-title":"Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy","volume":"13","author":"Russo","year":"2023","journal-title":"Life (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/cancers11010046","article-title":"Direct oral anticoagulant drugs: on the treatment of cancer-related venous thromboembolism and their potential anti-neoplastic effect","volume":"11","author":"Grandoni","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1055\/s-0039-1692682","article-title":"Apixaban suppresses the release of TF-positive microvesicles and restrains cancer cell proliferation through direct inhibition of TF\u2013fVIIa activity","volume":"119","author":"Featherby","year":"2019","journal-title":"Thromb Haemost"},{"key":"B31","doi-asserted-by":"publisher","first-page":"eaaw8405","DOI":"10.1126\/sciimmunol.aaw8405","article-title":"Myeloid cell-synthesized coagulation factor X dampens antitumor immunity","volume":"4","author":"Graf","year":"2019","journal-title":"Sci Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9761","DOI":"10.1038\/s41598-022-13174-5","article-title":"Association of factor XI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis","volume":"12","author":"Pallares Robles","year":"2022","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.3390\/jcm14176341","article-title":"Factor XI and cancer: physiopathological linkage and clinical perspectives","volume":"14","author":"Mauriello","year":"2025","journal-title":"J Clin Med"},{"key":"B34","year":"2022"},{"key":"B35","year":"2022"},{"key":"B36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jth.15599","article-title":"Extended anticoagulation treatment for cancer-associated thrombosis: rates of recurrence and bleeding beyond 6 months","volume":"20","author":"Moik","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1007\/s00520-019-4661-3","article-title":"Duration of anticoagulant therapy and venous thromboembolism recurrence in patients with cancer","volume":"27","author":"Khorana","year":"2019","journal-title":"Support Care Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jvsv.2021.05.007","article-title":"Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis","volume":"10","author":"Cires-Drouet","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102194","DOI":"10.1016\/j.eclinm.2023.102194","article-title":"Risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in cancer-associated thrombosis: a systematic review and meta-analysis","volume":"64","author":"van Hylckama Vlieg","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of hematology 2021 guidelines for management of venous thromboembolism in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","article-title":"Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis","volume":"18","author":"Lyman","year":"2013","journal-title":"Oncologist"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e70155","DOI":"10.1002\/jha2.70155","article-title":"Reduced versus full-dose direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"6","author":"Bakht","year":"2025","journal-title":"EJHaem"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1742549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:10:12Z","timestamp":1770138612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1742549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":42,"alternative-id":["10.3389\/fcvm.2026.1742549"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1742549","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1742549"}}